Neuron Guard

Neuron Guard

THE NEW STANDARD OF CARE FOR THE TARGETED TEMPERATURE MANAGEMENT OF PATIENTS

Founded 2013 Italy

Italy 3 employees Debt Financing Total: $1.86M Biotechnology, Health Care +1

Neuron Guard is an Italian medical device company that specializes in targeted temperature management for patients through their innovative technology. The company's flagship product, CB240_Aurora, is a portable hot or cold therapy system designed for selective brain temperature management and is composed of a collar/wrap powered by a smart control unit. Founded in 2013, Neuron Guard has made significant strides in their product development and market expansion. The company has obtained the CE mark as a class II medical device under MDR, allowing it to be sold in 5 countries in Europe. Furthermore, Neuron Guard has also received the ISO Certification 13485, demonstrating their commitment to quality and regulation compliance. With 11 patents and 3 patent pending applications, Neuron Guard has a strong intellectual property portfolio which extends across multiple countries. The company has also conducted a first-in-human pilot trial at the Cambridge University Hospital Neurocritical Care Unit, demonstrating the effectiveness and clinical benefits of CB240_Aurora. This study has been published in Neurocritical Care, showcasing the company's dedication to clinical validation and transparency. Neuron Guard has successfully secured a €550.00K Seed Round investment led by A11 Venture, CDP Venture Capital, Fondo Rilancio Startup in November 2021, highlighting investor confidence in the company's potential. With a focus on biotechnology and healthcare, Neuron Guard is poised for continued growth and impact in the medical device industry.

Funding Stage	Amount	Investors	Lead Investors	Date
Debt Financing	€650.00K	-		05 Nov 2021
Seed Round	€550.00K	3	A11 Venture, CDP Venture Capital +1	05 Nov 2021
Seed Round	€656.00K	1	A11 Venture	23 Dec 2015

Funding Stage

Amount

Investors

Lead Investors

Date

Debt Financing

€650.00K

05 Nov 2021

Seed Round

€550.00K

A11 Venture, CDP Venture Capital +1

05 Nov 2021

Seed Round

€656.00K

A11 Venture

23 Dec 2015

FAQ About Neuron Guard

THE NEW STANDARD OF CARE FOR THE TARGETED TEMPERATURE MANAGEMENT OF PATIENTS

Neuron Guard was founded in 2013.

Neuron Guard is headquartered in Italy.

Neuron Guard operates in Biotechnology, Health Care and Medical Devices. Its work centres on medical device company, temperature management, hot and cold therapy and portable therapy system.

Neuron Guard has approximately 3 employees.

Neuron Guard has completed 3 funding rounds, raising a total of $1.86M. The latest funding stage is Debt Financing.

Top alternatives and competitors to Neuron Guard include InnoCare Pharma, Zimmer MedizinSysteme GmbH, Remidio, Conkin Surgical Instruments Ltd., Signostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Neuron Guard and InnoCare Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Neuron Guard

Funding Rounds & Investors (3)

Neuron Guard Alternatives & Competitors

FAQ About Neuron Guard